Gold bars to be exempt from tariffs, White House clarifies
Investing.com - Dentsply (NASDAQ: XRAY) reported second quarter EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $936M versus the consensus estimate of $933.63M.
Guidance
Dentsply sees FY 2025 EPS of $1.80-$2.00 versus the analyst consensus of $1.88.
Dentsply sees FY 2025 revenue of $3.60B-$3.70B versus the analyst consensus of $3.65B.
Dentsply’s stock price closed at $13.68. It is down -13.47% in the last 3 months and down -43.80% in the last 12 months.
Dentsply saw 14 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Dentsply’s stock price’s past reactions to earnings here.
According to InvestingPro, Dentsply’s Financial Health score is "fair performance".
Check out Dentsply’s recent earnings performance, and Dentsply’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar